›Portfolio Companies

Past, Present and Future Leaders

InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.

Our Companies

Early stage IT and Healthcare Investing

Healthcare

Healthcare

ePocrates

Mon, 06/11/2012 - 10:36 -- admin

Epocrates enables health care providers to deliver better patient care by providing access to reliable clinical information through the use of mobile technology to support clinical decisions at the point of care. More than one in four U.S. physicians and nearly one in two medical students actively use Epocrates' mobile and web-based products. The company had an initial public offering in 2007.

Eiger BioPharmaceuticals

Mon, 06/11/2012 - 10:24 -- admin

Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger's pipeline includes preclinical new chemical entities from internal discovery efforts, as well as repurposed clinical and approved drugs shown to possess novel antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses.

Drais Pharmaceuticals

Mon, 06/11/2012 - 10:23 -- admin

Drais Pharmaceuticals is a pharmaceutical company headquartered in Bridgewater, New Jersey, dedicated to the development of novel therapeutic treatments that address unmet medical needs and provide significant benefits over currently available therapies.

AGTC

Mon, 06/11/2012 - 09:58 -- admin

Applied Genetic Technologies Corp (AGTC) develops therapeutics for patients with unmet medical needs utilizing the non-pathogenic adeno-associated virus to deliver therapeutic genes. AGTC secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus to gene therapy. AGTC has signed licenses to over 40 U.S. and foreign patents, and has five products in active development

Doximity

Wed, 05/23/2012 - 15:53 -- admin

Doximity is a free communication platform that helps connect medical professionals in 87 specialties to enable faster, smarter medical care. With Doximity, physicians can use their iPhone, iPad, Android device or computer to quickly connect with any U.S. physician to collaborate on patient treatment or identify appropriate experts for patient referrals.

KAI Pharmaceuticals

Wed, 05/23/2012 - 15:49 -- admin

KAI is a clinical-stage, biopharmaceutical company whose lead peptide product candidate, KAI-4169, is in development for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). CKD-MBD is characterized by an elevation of parathyroid hormone also referred to as secondary hyperparathyroidism. KAI was acquired by Amgen in 2012.

Restoration Robotics

Wed, 05/23/2012 - 15:45 -- admin

Restoration Robotics is revolutionizing the field of hair transplantation by developing and commercializing ARTAS, a state-of-the-art image-guided system that improves the follicular unit extraction process. The office-based device is capable of rapidly harvesting and implanting individual hairs with minimal invasion, automating the tedious manual surgical technique now being performed by hair transplant surgeons.

Integrated Diagnostics

Wed, 05/23/2012 - 15:33 -- admin

Integrated Diagnostics develops large-scale, blood-based molecular diagnostics that leverage advances in proteomics and genomics to detect disease at its earliest stage. It leverages emerging technologies to develop diagnostic products used by physicians and patients to manage complex and serious diseases like cancer, diabetes and Alzheimer's. The company’s products work through blood tests that can monitor tens to hundreds of disease markers simultaneously. Integrated Diagnostics is headquartered in Seattle, Washington.

BioMimetic

Wed, 05/09/2012 - 10:51 -- admin

BioMimetic Therapeutics develops and commercializes clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedic and sports medicine applications. BioMimetic has become a leader in regenerative medicine by providing new treatment options for the repair of bone, cartilage, tendons and ligaments. BioMimetic was acquired by Wright Medical Group in 2013.

CEBIX

Wed, 05/09/2012 - 10:42 -- admin

Cebix is a biopharmaceutical company focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of diabetic complications, initially peripheral neuropathy in patients with type 1 diabetes.

Pages

Subscribe to RSS - Healthcare
Facebook Google+ Twitter Email LinkedIn Share